Impact and management tool for identification and reduction of human Errors in pharmaceuticals Industry

  • Posted on: 31 January 2017
  • By: admin

Magazine Home


February 2017 ARTICLE LIST >>

PharmaTutor (February - 2017)

 

ISSN: 2347 - 7881
(Volume 5, Issue 2)

 

Received On: 21/09/2016; Accepted On: 17/10/2016; Published On: 01/02/2017

 

AUTHORS:
Suleman S. khoja 1*, Sohil S. khoja 1, Farhad S. Khoja 2, Shamim Khoja2, Narmin Pirani2
1 Resource person in pharmaceutical quality assurance and Audit Compliance, Vapi, India
2 Registered Pharmacist, Gujarat, India
*premukhoja@gmail.com

 

 

ABSTRACT: Human Error is commonly defined as “a failure of a planned action to achieve a desired outcome”.
GMPs clearly state in CFR 211.22 that “*the quality control unit has+…the authority to review Production records to assure that no errors have occurred or, if errors have occurred, that they have been fully investigated.” Let’s analyze this statement. If the FDA expects that errors be fully investigated, it is safe to assume that the term error is NOT a root cause. That’s why it needs to be fully investigated, hence determine the root cause of the human error.
In order to successfully achieve this goal, we have to understand how to improve the way we deal with these types of situations. review article accurately how to accurately identify human errors, determine when a deviation or nonconformance requires CAPA, and get started using human performance improvement tools and processes in your organization.

 

 

How to cite this article: Khoja SS, Khoja S, Khoja FS, Khoja S, Pirani N; Impact and management tool for identification and reduction of human Errors in pharmaceuticals Industry; PharmaTutor; 2017; 5(2); 7-13

 

[ABSTRACT WITH CITATION]   [VIEW AS HTML